SANTIAGO, Chile (AP) — Chile has become the first country in Latin America to sell cannabis-based medicines at pharmacies.
The pilot program was launched Wednesday at two pharmacies in the Chilean capital, which will sell the T100 and TC100 chronic pain-relief medicines made in Canada.
The program is financed by an alliance between Chile’s Alef Biotechnology and Canada’s Tilray under the supervision of the Chilean National Health institute.
Alef Biotechnology President Roberto Roizman says the viability of the program will be evaluated in six months to determine if it can be produced in Chile and exported.
Tilray is a pioneer in the research, production and distribution of cannabis-based medicines.
Chile has been joining an international trend of easing restrictions on marijuana for medical or personal use.
High Times to Acquire Spannabis, Europe’s Largest Cannabis Event
Cannabis Legalization Could Help Fund Education Needs In Maryland
High Folks: La Kia Gooch is Fighting to Stand Out
Arizona Saw 41 Percent Increase in Medical Marijuana Sales in 2018
News6 days ago
Cop Caught with Child Porn Serves 90 Days in Jail; Man Selling Weed Gets 5 Year Sentence
News7 days ago
Man Leaves Two Pounds of Pot in Uber, is Arrested Trying to Retrieve It
Science7 days ago
Is Psychedelic Healing in Your Genes? A Team of Scientists Seeks to Find Out
Culture6 days ago
10 Video Games to Play High as Hell in 2019
News5 days ago
Governor of New York Presents Plan to Legalize Recreational Marijuana
News4 days ago
Marijuana Legalization Bill Killed by Virginia Lawmakers
Activism3 days ago
Canadian Cannabis Activist Marc Emery Accused of Chronic Sexual Misconduct
News3 days ago
Iowa Mayor Charged For Growing 18 Marijuana Plants in Her Home